-
2nd Peking University Urology Academic Forum | Professor Xuesong Li: Innovation and Leadership in Integrated Management of Benign and Malignant Upper Urinary Tract Diseases
The 2nd Peking University Urology Academic Forum focused on the integrated and collaborative management of benign and malignant diseases of the upper urinary tract. As conference chair, Professor Xuesong Li from the Department of Urology at Peking University First Hospital shared his team’s long-standing experience and insights into the field’s major clinical challenges, key innovations,…
-
2nd Peking University Urology Academic Forum | Professor Chaohui Gu: Umbilical Artery Ligament Suspension—A New Breakthrough for Immediate Urinary Continence After Radical Prostatectomy
At the 2nd Peking University Urology Academic Forum and the 80th Anniversary Celebration of the Department of Urology at Peking University First Hospital, Oncology Frontier – UroStream interviewed Professor Chaohui Gu from the Department of Urology, The First Affiliated Hospital of Zhengzhou University.
-
2nd Peking University Urology Academic Forum | Professor Wei Zhu: FANS Technology Revolutionizes Flexible Ureteroscopic Lithotripsy Through Clinician–Engineer Innovation
Flexible ureteroscopic lithotripsy is an important treatment modality for upper urinary tract stones. However, conventional procedures are associated with several limitations, including low stone-free rates, elevated intrarenal pressure during surgery, and increased risks of postoperative infection and ureteral stricture.
-
International Perspectives from EBMT | Professor Florent Malard: New Frontiers in Microbiome-Based Therapy for the Treatment and Prevention of Graft-versus-Host Disease
Graft-versus-host disease (GVHD) remains one of the most severe complications following hematopoietic stem cell transplantation. Among its manifestations, acute gastrointestinal GVHD is particularly challenging to manage. Despite standard therapies, a substantial proportion of patients fail treatment, and no approved therapeutic options currently exist for those with refractory disease, representing a major unmet medical need.
-
Professor Liqun Zou: Advances in the Diagnosis and Treatment of Peripheral T-Cell Lymphoma | 2026 CACA Western Integrated Oncology Conference
Amid the vibrant renewal of spring, the 2026 CACA Western Integrated Oncology Conference was grandly convened in Chengdu, Sichuan. The meeting brought together leading oncology experts from across China to explore the frontiers of precision oncology and advance integrated, whole-course cancer care.
-
Professor Qingyuan Zhang: From Strategic Deployment of Novel Therapies to Integrated Care—Exploring New Survival Pathways in R/R DLBCL | 2026 CACA Western Integrated Oncology Conference
Amid the vibrant renewal of spring, the 2026 CACA Western Integrated Oncology Conference was grandly convened in Chengdu, Sichuan. The meeting brought together leading oncology experts from across China to explore the frontiers of precision oncology and advance integrated, whole-course cancer care.
-
AOT 2026 | Professor Xiaojun Huang Leads In-Depth Discussions on Three Major Controversies in Hematopoietic Stem Cell Transplantation
Academic progress begins with debate and matures through consensus. As a cornerstone therapy for hematologic diseases, hematopoietic stem cell transplantation (HSCT) continues to face numerous unresolved controversies and clinical dilemmas. Centered on the theme “The Art of Transplantation,” the 2026 Beijing International Hematopoietic Stem Cell Transplantation Conference (AOT 2026) brought together leading experts from around…
Connecting Medical Expertise through Media
